Search results
AbbVie Inc. (NYSE:ABBV) Shares Sold by Vanguard Group Inc.
ETF DAILY NEWS· 5 days agoVanguard Group Inc. trimmed its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 0.2% during the 4th quarter, according to its most recent filing with the Securities and ...
Beese Fulmer Investment Management Inc. Cuts Stock Holdings in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 3 days agoBeese Fulmer Investment Management Inc. reduced its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 2.6% during the first quarter, Holdings Channel.com reports. The institutional ...
GAMMA Investing LLC Has $3.53 Million Stock Position in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 3 days agoGAMMA Investing LLC boosted its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 18.9% during the first quarter, according to the company in its most recent filing with the ...
AbbVie Inc. (NYSE:ABBV) Holdings Cut by Carolina Wealth Advisors LLC
ETF DAILY NEWS· 3 days agoCarolina Wealth Advisors LLC decreased its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 5.2% during the 1st quarter, according to its most recent filing ...
AbbVie (NYSE:ABBV) Stock Price Up 1.5% on Analyst Upgrade
ETF DAILY NEWS· 5 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shares rose 1.5% during trading on Tuesday after Piper Sandler raised their price target on the stock from $185.00 to $190.00. Piper ...
AbbVie Inc. (NYSE:ABBV) Shares Bought by First Financial Bank Trust Division
ETF DAILY NEWS· 4 days agoFirst Financial Bank Trust Division boosted its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 967.2% during the 1st quarter, according to the company in its ...
Why AbbVie (ABBV) is a Great Dividend Stock Right Now
Zacks via Yahoo Finance· 4 days agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is...
B. Riley Wealth Advisors Inc. Sells 15,193 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 5 days agoB. Riley Wealth Advisors Inc. trimmed its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 10.4% during the fourth quarter, Holdings Channel.com reports. The ...
AbbVie stock price forecast: $200 on the cards? | Invezz
Invezz· 3 days agoOn June 20, 2024, AbbVie Inc. (NYSE:ABBV) announced that it has received FDA approval for expanding the use of its interleukin-23 (IL-23) inhibitor, Skyrizi, to treat adults ...
Bath Savings Trust Co Acquires 196 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 3 days agoBath Savings Trust Co increased its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 1.0% during the 1st quarter, according to its most recent Form 13F filing ...